Track Group Inc. (TRCK)
OTCQX OTCQX Primary 
TAP's Innovations on Track: Topo Chico Hard Debuts Margarita Beverages
Molson Coors is focused on portfolio premiumization and innovations. Topo Chico Hard Seltzer is extending its portfolio into flavored alcoholic beverages.
Deutsche Bank Sees Full-Year Targets on Track After Profit, Revenue Rise
The group saw growth in its investment bank, private bank and asset management arms offsetting a decline in its corporate bank.
Chinese Robotaxi Firm Pony AI on Faster Track to Profit After Cost Cuts, CTO Says
The Chinese robotaxi company says it is getting closer to profitability after clearing a cost hurdle its chief technology officer believes can help unlock the commercialization of driver-less vehicles.
Pepsi and Other Food Stocks Are Broken. How They Get Back on Track.
Big food companies raised prices more than they needed to during the pandemic, and are now paying the price as consumers look for cheaper—and healthier—alternatives
Verizon Posts Earnings Beat, Stays on Track for Full-Year Outlook
Verizon Communications surpassed expectations with its first-quarter earnings and said it is still on course to meet its yearly goals.
Tariff-Resistant Abbott Laboratories on Track for New Highs
Abbott Laboratories NYSE: ABT is not immune to the impact of tariffs on its medical device business. However, the company's diversified business is tariff-resistant, and moves are being made to strengthen it further.
Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy'
VERV's VERVE-102 showed an impressive 69% LDL-C reduction in its early Phase 1b data. Also, LLY may opt into VERVE-102's development later this year, which would help VERV by covering one-third of the R&D costs. Similarly, VERV's pipeline includes VERVE-201 for HoFH and refractory hypercholesterolemia, as well as VERVE-301 in collaboration with Lilly.
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate
The FDA bestows a Fast Track designation to ARCT's sa-mRNA vaccine candidate, ARCT-2304, for active immunization to prevent pandemic influenza A virus H5N1.
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
The FDA's fast track designations will facilitate rapid development and expedited review of ALLO's autoimmune disease candidate.
Pinnacle Food Group: Not A Buy Yet, But This AgTech IPO Is On The Right Track
Pinnacle Food Group, a hydroponic farming company, is preparing for its IPO amidst a volatile market, targeting urban households and communities with innovative indoor growing systems. The hydroponic farming market is projected to grow significantly due to urbanization and decreasing arable land, with Pinnacle's scalable models and FaaS services positioning it well for growth. Despite impressive revenue growth and strong financials, the IPO valuation appears high; it's recommended to hold off on the IPO and consider buying on the secondary market.
OKYO Pharma CEO discusses FDA Fast Track filing for urcosimod - ICYMI
OKYO Pharma Ltd (NASDAQ:OKYO) CEO Gary Jacob talked with Proactive about the company's recent developments, including the formal naming of its drug candidate OK-101 as urcosimod. Jacob discussed the company's recent Fast Track application to the FDA, aimed at accelerating the regulatory pathway for urcosimod.
Penguin Solutions: Growth Momentum Still On Track
I maintain a bullish rating on Penguin Solutions due to strong AI-related demand and solid financial performance, validated by 2Q25 results. PENG reported $366 million in revenue, up 28% y/y, with significant growth in Advanced Computing and Integrated Memory segments, and improved gross margins. Management's positive pipeline commentary and strong demand from hyperscalers suggest continued revenue growth and successful AI implementations into FY '26.
